Market Size of Global Mastopexy Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.70 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Mastopexy Market Analysis
The Mastopexy market studied is expected to grow with an estimated CAGR of 5.7% over the forecast period (2022-2027).
As the COVID-19 pandemic progressed with new strains, the safety of ablative resurfacing lasers, micro-needling, and dermatological surgery procedures also seemed to be unsafe. Additionally, the slowing economy and reduced discretionary spending discourage customers from undergoing expensive cosmetic treatments, thus imposing practical restrictions. The Plastic Surgery Statistics Report from the year, 2020 states that a total population of 87,051 patients underwent mastopexy surgery in 2020. Therefore the preference for aesthetic surgeries among the global population is expected to drive the growth of the market during the pandemic period.
The rising female geriatric population and growing demands for aesthetic procedures are estimated to drive market growth during the forecast period. Increased healthcare expenditures and the growing demands for outpatient surgeries are boosting market growth. Additionally, the increasing product launches are expected to contribute to the growth of the market. For, Instance, In May 2021, GC Aesthetics Inc. launched its next generation of breast implants, PERLE. PERLE is a highly innovative line of smooth breast implants that features proprietary surface technology, GCA's industry-leading gel technology, and an enhanced version of the safety features that have underpinned GCA's long-term excellent safety record. In February 2021, Galderma received the approval of RESTYLANE DEFYNE by the United States Food and Drug Administration for the augmentation and correction of mild to moderate chin retrusion for adults. However, factors such as the high cost of mastopexy followed by complications of the surgery are estimated to restrain the market growth during the forecast period.
Mastopexy Industry Segmentation
As per the scope of the report, mastopexy, also known as breast lift, is a cosmetic breast surgery procedure that lifts the breasts and shapes sagging or ptotic breast while minimizing visible scars. The procedure also eliminates excess skin around the breasts and shrinks the areola. The Mastopexy Market is segmented by Technique (Crescent Breast Lift, Benelli Lift, Benelli-Lollipop Lift, and Full Mastopexy), By End-Use (Hospitals, Ambulatory Surgery Centers, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Technique | |
Benelli Lift | |
Crescent Breast Lift | |
Benelli-Lollipop Lift | |
Full Mastopexy |
By End use | |
Speciality Clinics | |
Hospitals |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Mastopexy Market Size Summary
The mastopexy market is poised for significant growth, driven by increasing demand for aesthetic procedures and the rising female geriatric population. The market is experiencing a surge in healthcare expenditures and a growing preference for outpatient surgeries, which are contributing to its expansion. The introduction of innovative products, such as GC Aesthetics Inc.'s PERLE breast implants and Galderma's RESTYLANE DEFYNE, is further propelling market growth. Despite the high costs and potential complications associated with mastopexy surgeries, the preference for aesthetic enhancements and the restoration of breast volume continue to drive market dynamics. The full mastopexy segment, particularly relevant for older women and breast cancer patients, holds a significant share of the market, supported by the high incidence of breast cancer and the increasing number of breast augmentations.
North America dominates the mastopexy market, fueled by a strong demand for cosmetic procedures and increased disposable income among women. The region's market growth is further bolstered by the prevalence of breast cancer, which necessitates procedures like mastopexy. The United States, in particular, sees a high demand for breast augmentations, contributing to the market's expansion. The competitive landscape of the mastopexy market is characterized by the presence of major players such as Allergan, Sientra, Inc., and Johnson & Johnson, among others. Recent developments, including CollPlant's 3D bioprinted regenerative breast implant program and GC Aesthetics' NAC reconstruction implant, highlight the ongoing innovation and strategic initiatives within the market, ensuring its continued growth during the forecast period.
Global Mastopexy Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing adoption of breast lifting procedures
-
1.2.2 Growing prominence on physical appearance
-
1.2.3 Rising female geriatric population
-
1.2.4 Rising trend of aesthetic procedures
-
-
1.3 Market Restraints
-
1.3.1 High cost of these procedures
-
1.3.2 Post-surgery complications
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Technique
-
2.1.1 Benelli Lift
-
2.1.2 Crescent Breast Lift
-
2.1.3 Benelli-Lollipop Lift
-
2.1.4 Full Mastopexy
-
-
2.2 By End use
-
2.2.1 Speciality Clinics
-
2.2.2 Hospitals
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 United Kingdom
-
2.3.2.2 Germany
-
2.3.2.3 France
-
2.3.2.4 Spain
-
2.3.2.5 Italy
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia Pacific
-
2.3.3.1 India
-
2.3.3.2 Japan
-
2.3.3.3 China
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of the Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Mastopexy Market Size FAQs
What is the current Global Mastopexy Market size?
The Global Mastopexy Market is projected to register a CAGR of 5.70% during the forecast period (2024-2029)
Who are the key players in Global Mastopexy Market?
Allergan, Sientra, Integra, Polytech and Johnson & Johnson are the major companies operating in the Global Mastopexy Market.